Bill > S3474

This bill, titled the "Cannabinoid Safety and Regulation Act," proposes to amend the Federal Food, Drug, and Cosmetic Act to establish a comprehensive regulatory framework for cannabis and cannabinoid products. Key provisions include the Food and Drug Administration (FDA) regulating these products, defining what constitutes adulterated and misbranded cannabinoid products, and requiring registration for facilities involved in their manufacturing, processing, or distribution. The bill also mandates specific labeling requirements, including warnings and ingredient disclosures, and prohibits certain product formulations, such as those appealing to minors or containing specific artificial flavors in electronic delivery systems. Furthermore, it addresses public health by funding surveillance and data collection on cannabis use and its effects, and aims to prevent underage cannabis use through grants. A significant portion of the bill is dedicated to preventing cannabis-impaired driving, including research, public awareness campaigns, and grants to states for prevention programs, with the ultimate goal of establishing a national standard for cannabis impairment. The bill also clarifies that it does not limit the authority of federal, state, tribal, or local governments to enact stricter regulations, while also preventing states from creating labeling requirements that are not identical to federal ones.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/3474/all-info